1st Middle East and Africa Osteoporosis Meeting opens in Dubai

October 19, 2011

Doctors and clinical investigators from the throughout the Middle East gathered today in Dubai for the opening of the International Osteoporosis Foundation's (IOF) 1st Middle-East and Africa Osteoporosis Meeting.

The meeting, taking place at the Intercontinental Dubai Festival City to October 22, 2011,has received the official patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, U.A.E. Minister of Finance, and President of the Dubai Department of Health and Medical Services. HE Abdul Rhaman Al Owais, Minister of Culture, Youth and Community Development and UAE Acting Minister of Health, welcomed participants at the opening ceremony.

The 1st Middle-East & Africa Osteoporosis Meeting features presentations by leading international speakers and key experts from throughout the region. Its clinically-oriented scientific programme includes 17 plenary lectures, five meet-the-expert sessions, five satellite symposia and an orthopedic roundtable. IOF President Professor John A. Kanis commented, "The great number of attendees from more than 50 countries indicates that there is a real need for regionally-focused meetings that present both a well-developed clinical programme and high standards of clinical research. Participants will find that this is a fertile venue for education, innovation and collaboration."

Dr. Basel Masri, osteoporosis expert from Jordan and scientific co-chair of the meeting highlighted the significance of the new regional research to be presented in Dubai. "Osteoporosis is a serious health challenge in the region. We believe that this meeting will serve to both improve patient care and stimulate regional research. Young scientists in particular will benefit from this high-profile venue in which to present their research findings to an international audience." Research abstracts from the meeting have been published in the field's leading journal, 'Osteoporosis International'.

The meeting will close with a media event launching a landmark report 'The Middle East and Africa Regional Audit: Epidemiology, Costs and Burden of Osteoporosis 2011'. The report, the first to compile available information for the entire region, will be available on the IOF website at www.iofbonehealth.org
-end-
About IOF

The International Osteoporosis Foundation (IOF) is a non-profit, nongovernmental umbrella organization dedicated to the worldwide fight against osteoporosis, the disease known as "the silent epidemic". IOF's members - committees of scientific researchers, patient, medical and research societies and industry representatives from around the world - share a common vision of a world without osteoporotic fractures. IOF now represents 199 member societies, including 21 member societies in 17 locations within the Middle-East and Africa region. http://www.iofbonehealth.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.